Acorah Software Products - Accounts Production 16.5.460 false true 31 December 2023 1 January 2023 false 1 January 2024 31 December 2024 31 December 2024 08826936 Testbusters UK Holdings Ltd Rohan Agarwal Ludovico Callerio Testbusters SRL false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08826936 2023-12-31 08826936 2024-12-31 08826936 2024-01-01 2024-12-31 08826936 frs-core:CurrentFinancialInstruments 2024-12-31 08826936 frs-core:Non-currentFinancialInstruments 2024-12-31 08826936 frs-core:NetGoodwill 2024-12-31 08826936 frs-core:NetGoodwill 2024-01-01 2024-12-31 08826936 frs-core:NetGoodwill 2023-12-31 08826936 frs-core:PlantMachinery 2024-12-31 08826936 frs-core:PlantMachinery 2024-01-01 2024-12-31 08826936 frs-core:PlantMachinery 2023-12-31 08826936 frs-core:ShareCapital 2024-12-31 08826936 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 08826936 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 08826936 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 08826936 frs-bus:SmallEntities 2024-01-01 2024-12-31 08826936 frs-bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 08826936 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 08826936 frs-bus:OrdinaryShareClass1 2024-01-01 2024-12-31 08826936 frs-bus:OrdinaryShareClass1 2024-12-31 08826936 1 2024-01-01 2024-12-31 08826936 frs-core:DeferredTaxation 2024-01-01 2024-12-31 08826936 frs-core:DeferredTaxation 2023-12-31 08826936 frs-core:DeferredTaxation 2024-12-31 08826936 frs-bus:Director1 2024-01-01 2024-12-31 08826936 frs-bus:Director2 2024-01-01 2024-12-31 08826936 frs-bus:Director3 2024-01-01 2024-12-31 08826936 frs-countries:EnglandWales 2024-01-01 2024-12-31 08826936 2022-12-31 08826936 2023-12-31 08826936 2023-01-01 2023-12-31 08826936 frs-core:CurrentFinancialInstruments 2023-12-31 08826936 frs-core:Non-currentFinancialInstruments 2023-12-31 08826936 frs-core:ShareCapital 2023-12-31 08826936 frs-core:RetainedEarningsAccumulatedLosses 2023-12-31 08826936 frs-bus:OrdinaryShareClass1 2023-01-01 2023-12-31
Registered number: 08826936
6Med Ltd
Unaudited Financial Statements
For The Year Ended 31 December 2024
Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
6Med Ltd
Contents
Contents
Page
Company Information 1
Accountants' Report 2
Statement of Financial Position 3—4
Notes to the Financial Statements 5—8
Page 1
6Med Ltd
Company Information
For The Year Ended 31 December 2024
Company Information
Directors Testbusters UK Holdings Ltd
Rohan Agarwal
Ludovico Callerio
Company Number 08826936
Registered Office SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Accountants Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Page 1
Page 2
6Med Ltd
Accountants' Report
For The Year Ended 31 December 2024
Accountants' Report
Chartered Accountants' report to the directors on the preparation of the unaudited statutory accounts of 6Med Ltd For The Year Ended 31 December 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of 6Med Ltd for the year ended 31 December 2024 which comprise the Income Statement, the Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given to us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-and-guidance.
This report is made solely to the directors of 6Med Ltd , as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of 6Med Ltd and state those matters that we have agreed to state to the directors of 6Med Ltd , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than 6Med Ltd and its directors, as a body, for our work or for this report.
It is your duty to ensure that 6Med Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of 6Med Ltd . You consider that 6Med Ltd is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit of the accounts of 6Med Ltd . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Signed
Sterling Accounting Solutions Ltd
23/09/2025
Sterling Accounting Solutions Ltd
Chartered Accountants
SAS House
Chipperfield Road
Kings Langley
Hertfordshire
WD4 9JB
Page 2
Page 3
6Med Ltd
Statement of Financial Position
As At 31 December 2024
Statement of Financial Position
Registered number: 08826936
2024 2023
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 65,875 81,375
Tangible Assets 5 11,787 13,261
77,662 94,636
CURRENT ASSETS
Debtors 6 185,000 -
Cash at bank and in hand 32,844 206,518
217,844 206,518
Creditors: Amounts Falling Due Within One Year 7 (29,158 ) (44,495 )
NET CURRENT ASSETS (LIABILITIES) 188,686 162,023
TOTAL ASSETS LESS CURRENT LIABILITIES 266,348 256,659
Creditors: Amounts Falling Due After More Than One Year 8 - (12,679 )
PROVISIONS FOR LIABILITIES
Deferred Taxation (2,947 ) (3,316 )
NET ASSETS 263,401 240,664
CAPITAL AND RESERVES
Called up share capital 10 1,010 1,010
Income Statement 262,391 239,654
SHAREHOLDERS' FUNDS 263,401 240,664
Page 3
Page 4
6Med Ltd
Statement of Financial Position (continued)
As At 31 December 2024
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
On behalf of the board
Rohan Agarwal
Director
Ludovico Callerio
Director
23/09/2025
The notes on pages 5 to 8 form part of these financial statements.
Page 4
Page 5
6Med Ltd
Notes to the Financial Statements
For The Year Ended 31 December 2024
Notes to the Financial Statements
1. General Information
6Med Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 08826936 . The registered office is SAS House, Chipperfield Road, Kings Langley, Hertfordshire, WD4 9JB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
These financial statements have been prepared in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland" ("FRS 102") and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It is amortised to income statement over its estimated economic life of 10 years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Software 10 years straight line
Page 5
Page 6
6Med Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
2.5. Financial Instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Page 6
Page 7
6Med Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2023: 4)
3 4
4. Intangible Assets
Goodwill
£
Cost
As at 1 January 2024 155,000
As at 31 December 2024 155,000
Amortisation
As at 1 January 2024 73,625
Provided during the period 15,500
As at 31 December 2024 89,125
Net Book Value
As at 31 December 2024 65,875
As at 1 January 2024 81,375
5. Tangible Assets
Software
£
Cost
As at 1 January 2024 14,735
As at 31 December 2024 14,735
Depreciation
As at 1 January 2024 1,474
Provided during the period 1,474
As at 31 December 2024 2,948
Net Book Value
As at 31 December 2024 11,787
As at 1 January 2024 13,261
6. Debtors
2024 2023
£ £
Due after more than one year
Amounts owed by group undertakings 185,000 -
Page 7
Page 8
6Med Ltd
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2024
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Bank loans and overdrafts - 8,950
Corporation tax (2,914 ) -
Other creditors 32,072 35,545
29,158 44,495
8. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans - 12,679
9. Provisions for Liabilities
Deferred Tax Total
£ £
As at 1 January 2024 3,316 3,316
Deferred taxation (369 ) (369 )
Balance at 31 December 2024 2,947 2,947
10. Share Capital
2024 2023
Allotted, called up and fully paid £ £
101,000 Ordinary Shares of £ 0.01 each 1,010 1,010
11. Related Party Transactions
At the year end 6Med Ltd owed £19,942 (2023: £9,619) to companies under common control. This amount is included within other creditors.
At the year end 6Med Ltd was owed £185,000 (2023: £Nil) by it's parent company. This amount is included within amounts owed by group undertakings.
12. Parent Undertaking and Controlling Party
The company's immediate and parent undertaking is Testbusters UK Holdings Ltd . Testbusters UK Holdings Ltd was incorporated in England and Wales. 
The ultimate controlling party is Testbusters SRL who controls 100% of the shares of Testbusters UK Holdings Ltd .
Page 8